Medicare Enrolled

Dr. Ned Nafziger

Physical Medicine & Rehabilitation · Canton, OH
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
4105 HOLIDAY ST NW, Canton, OH 44718
3304942097
In practice since 2006 (20 years)
NPI: 1538109426 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nafziger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nafziger? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nafziger

Dr. Ned Nafziger is a physical medicine & rehabilitation specialist in Canton, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Nafziger performed 10,114 Medicare services across 398 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nafziger received a total of $6,916 from 67 pharmaceutical and/or device companies across 372 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physical medicine & rehabilitation. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nafziger is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 5% volume in OH $6,916 industry payments

Medicare Practice Summary

Medicare Utilization ↗
10,114
Medicare services
Top 5% in OH for physical medicine & rehabilitation
398
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~506 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
AbobotulinumtoxinA injection, 5 units
An injection of abobotulinumtoxinA administered in a quantity of 5 units.
9,520 $7 $12
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
291 $71 $146
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
82 $123 $263
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
43 $140 $316
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 42 $57 $106
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
39 $1 $7
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
31 $88 $201
Chemical nerve block injection, 5+ arm/leg muscles
Injection of a chemical agent to paralyze five or more muscles in the first extremity treated.
29 $132 $340
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
22 $82 $188
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
15 $120 $247
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,916
Total received (2018-2024)
Avg $988/year across 7 years
Top 11% in OH for physical medicine & rehabilitation
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
372
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,916 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,516
2023
$1,399
2022
$987
2021
$1,102
2020
$708
2019
$491
2018
$713

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$249
ABBVIE INC.
$227
E.R. Squibb & Sons, L.L.C.
$125
Avadel CNS Pharmaceuticals, LLC
$102
Eisai Inc.
$89
SK Life Science, Inc.
$66
Lilly USA, LLC
$65
Lundbeck LLC
$64
EMD Serono, Inc.
$61
Amgen Inc.
$57
Xeris Pharmaceuticals, Inc.
$52
Vanda Pharmaceuticals Inc.
$51
TG Therapeutics, Inc.
$43
HARMONY BIOSCIENCES LLC
$43
Teva Pharmaceuticals USA, Inc.
$42
Neurocrine Biosciences, Inc.
$32
Corium, LLC
$31
ACADIA Pharmaceuticals Inc
$27
Kyowa Kirin, Inc.
$23
Grifols USA, LLC
$20
Axsome Therapeutics, Inc.
$18
GE HEALTHCARE
$15
Otsuka America Pharmaceutical, Inc.
$13
Top 3 companies account for 39.6% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$751
ABBVIE INC.
$425
Amgen Inc.
$423
E.R. Squibb & Sons, L.L.C.
$409
SK Life Science, Inc.
$360
Eisai Inc.
$288
Lilly USA, LLC
$247
JAZZ PHARMACEUTICALS INC.
$230
Alexion Pharmaceuticals, Inc.
$214
Lundbeck LLC
$211
Novartis Pharmaceuticals Corporation
$187
EMD Serono, Inc.
$185
GENZYME CORPORATION
$173
Sumitomo Pharma America, Inc.
$165
Kyowa Kirin, Inc.
$148
ACADIA Pharmaceuticals Inc
$147
Avadel CNS Pharmaceuticals, LLC
$126
Ipsen Biopharmaceuticals, Inc
$125
Teva Pharmaceuticals USA, Inc.
$123
Neurocrine Biosciences, Inc.
$122
Biohaven Pharmaceuticals, Inc.
$116
Axsome Therapeutics, Inc.
$114
Amneal Pharmaceuticals LLC
$103
Harmony Biosciences LLC
$98
Supernus Pharmaceuticals, Inc.
$89
Avanir Pharmaceuticals, Inc.
$80
Vanda Pharmaceuticals Inc.
$76
Horizon Therapeutics plc
$75
Acorda Therapeutics, Inc
$63
HARMONY BIOSCIENCES LLC
$55
Janssen Pharmaceuticals, Inc
$54
Biogen, Inc.
$54
Xeris Pharmaceuticals, Inc.
$52
TG Therapeutics, Inc.
$43
Neurelis, Inc.
$42
Allergan, Inc.
$41
Merck Sharp & Dohme Corporation
$40
UPSHER-SMITH LABORATORIES LLC
$40
Adamas Pharmaceuticals, Inc.
$39
EISAI INC.
$34
Biohaven Pharmaceutical Holding Company Ltd.
$34
Mallinckrodt Hospital Products Inc.
$32
Corium, LLC
$31
Jazz Pharmaceuticals Inc.
$31
AbbVie Inc.
$29
Collegium Pharmaceutical, Inc.
$29
GE HEALTHCARE
$28
ARGENX US, INC.
$25
IMPEL PHARMACEUTICALS INC.
$25
Upsher-Smith Laboratories LLC
$23
Sunovion Pharmaceuticals Inc.
$22
Celgene Corporation
$21
Grifols USA, LLC
$20
AQUESTIVE THERAPEUTICS, INC.
$18
AbbVie, Inc.
$18
Scilex Pharmaceuticals Inc.
$17
CSL Behring
$16
Vertical Pharmaceuticals, LLC
$16
Impax Laboratories, Inc.
$15
PFIZER INC.
$14
Medtronic Vascular, Inc.
$14
Avion Pharmaceuticals
$14
Cala Health, Inc.
$14
Otsuka America Pharmaceutical, Inc.
$13
Genentech USA, Inc.
$13
Mitsubishi Tanabe Pharma America, Inc.
$12
Bausch Health US, LLC
$11
Top 3 companies account for 23.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · Azstarys · BELSOMRA · BOTOX · BRIUMVI · Briviact · CALA TRIO · DUOPA · Dhivy · Duopa · Dysport · ELIQUIS · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · FABRAZYME · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Hetlioz · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · LATUDA · LUMRYZ · Leqembi · MAVENCLAD · MIGRANAL · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OSMOLEX ER · OXTELLAR XR · Ocrevus · POMPE - DISEASE · PONVORY · QULIPTA · RYTARY · Radicava · Rebif · Reveal LINQ · Rystiggo · SOLIRIS · SPINRAZA · SUNOSI · SYMPAZAN · Soliris · Sunosi · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VYALEV · VYEPTI · VYVGART · Vimpat · WAKIX · Wakix · XARELTO · XYWAV · ZEPOSIA · ZTLido · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a physical medicine & rehabilitation specialist in Canton?
Compare physical medicine & rehabilitations in the Canton area by procedure volume, costs, and industry payment transparency.
Browse physical medicine & rehabilitations nearby

Geographic Context

Physical medicine & rehabilitations within 10 mi
27
Per 100K population
7.2
County median income
$65,740
Nearest hospital
MERCY MEDICAL CENTER
2.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Nafziger is a mixed practice specialist, with above-average Medicare volume (top 5% in OH), with low-engagement industry engagement in the top 11% of OH peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Nafziger experienced with abobotulinumtoxina injection, 5 units?
Based on Medicare claims data, Dr. Nafziger performed 9,520 abobotulinumtoxina injection, 5 units services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nafziger receive payments from pharmaceutical companies?
Yes. Dr. Nafziger received a total of $6,916 from 67 companies across 372 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nafziger's costs compare to other physical medicine & rehabilitations in Canton?
Dr. Nafziger's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nafziger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →